Revista: | Brazilian Journal of Pharmaceutical Sciences |
Base de datos: | PERIÓDICA |
Número de sistema: | 000451530 |
ISSN: | 1984-8250 |
Autors: | Ismail, Bahiah1 Shafei, Mohd Nazri1 Harun, Azian1 Ali, Saedah1 Omar, Mahamarowi1 Deris, Zakuan Zainy1 |
Institucions: | 1Universiti Sains Malaysia, School of Medical Sciences, Kota Bharu, Kelantan. Malasia |
Any: | 2021 |
Volum: | 57 |
País: | Brasil |
Idioma: | Inglés |
Tipo de documento: | Artículo |
Enfoque: | Aplicado, descriptivo |
Resumen en inglés | Sub-therapeutic doses, shorter duration of therapy, female gender, bacteremia, and renal impairment were among independent predictors of polymyxin B treatment failure. In this study, we found an association between inappropriate doses of polymyxin B (<15000 or >25000 unit/kg/day) and renal impairment. Inappropriate doses of polymyxin B were significantly associated with CrCl 20-50 mL/min (p = 0.021, ORadj 6.660, 95% CI 1.326, 33.453) and CrCl <20 mL/min (p = 0.001, ORadj 22.200, 95% CI 3.481, 141.592). By conducting sub-group analysis only using subjects with appropriate dosage, renal impairment was not associated with polymyxin B treatment failure, thus indicating that treatment failure was due to an inappropriate dose of polymyxin B, rather than renal impairment. In conclusion, renal impairment was not directly associated with treatment failure but was due to an inappropriate dosage of polymyxin B after renal adjustment |
Disciplines | Medicina |
Paraules clau: | Farmacología, Microbiología, Nefrología, Antibióticos, Polimixina B, Insuficiencia renal |
Keyword: | Pharmacology, Microbiology, Nephrology, Antibiotics, Polymyxin B, Renal failure |
Text complet: | Texto completo (Ver HTML) Texto completo (Ver PDF) |